Flavonoid compounds and their synthesis method and use

Through the selective methylation, oxidation and benzylation reactions of hesperin, flavonoid compounds with anti-triple-negative breast cancer activity were synthesized, which solved the problem of low bioavailability of hesperin and achieved the anti-triple-negative type Effective drug development for breast cancer.

CN113956227BActive Publication Date: 2024-11-12GUANGXI MEDICAL UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202010701196.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2020-07-20
Publication Date
2024-11-12
Estimated Expiration
2040-07-20

AI Technical Summary

Technical Problem

Hesperin is poor in water solubility and low in bioavailability, which limits its medicinal value in the treatment of anti-trinomic breast cancer, and it is difficult for the prior art to effectively develop its anti-tumor activity.

Method used

Hesperin was semi-synthesized through reaction steps such as selective methylation, oxidation, and benzylation to synthesize 32 flavonoid compounds, including 14 flavonoid aglyconjugates and 18 flavonoid glycosides, and glycoside condensation reaction and debenzylating were used to synthesize 32 flavonoid compounds. The base reaction produces a compound with potential anti-trinomic breast cancer activity.

Benefits of technology

Successfully increased the bioavailability of hesperenin, resulting in a variety of new compounds that showed significant anti-triple-negative breast cancer cell growth inhibition, providing potential drug or lead compound options.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN113956227B_ABST
    Figure CN113956227B_ABST
Patent Text Reader

Abstract

Semi-synthetic flavonoid compounds and their anti-inflammatory uses. The present invention belongs to the field of medical technology, specifically the synthesis of derivatives of natural products and their applications in anti-inflammatory aspects, and more specifically the synthesis method of flavonoid compounds and their applications in anti-inflammatory aspects. The present invention uses hesperetin as a raw material to synthesize flavonol aglycones, and finally synthesizes flavonoid glycosides by debenzylation and acetyl reaction. A total of 32 flavonoid compounds were synthesized, including 14 flavonoid aglycones and 18 flavonoid glycosides, of which 15 are known compounds and 17 are unreported compounds. Some compounds show good in vitro anti-inflammatory activity and may become anti-inflammatory drugs or lead compounds.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of medical technology, and specifically relates to the synthesis of derivatives of natural products and their application in anti-cancer. Background Art

[0002] Flavonoids are a class of natural organic compounds composed of 15 carbon atoms (C 6 -C 3 -C 6 ), the skeleton contains two benzene rings, the two benzene rings are connected by a C 3 Partial bridge, C 3 The part can be a fatty chain or it can be connected with C 6 Some of them form five-membered or six-membered oxygen heterocycles. Flavonoids are widely found in food and medicine, and are one of the main active ingredients in many natural medicinal plants. They have a wide range of biological activities, such as anti-inflammatory, antioxidant, anti-tumor, cardiovascular protection, antibacterial, hypoglycemic and other pharmacological effects. Flavonoids are not only structurally diverse, but also different types of compounds exhibit different biological activities and functions.

[0003] It is reported that more than 10 million tons of citrus peel residues are produced nationwide each year, containing about 10,000 tons of flavonoids, among which the dihydroflavonoid compounds hesperidin and hesperetin have high contents, about 2.9% and 1.0% respectively, which have multiple biological activities such as anti-inflammatory, antioxidant, anti-tumor, cardiovascular protection, and immunomodulation. However, hesperidin and hesperetin cannot exert their pharmacological effects due to their poor water solubility and low bioavailability, which limits the development of their potential medicinal value. In the process of research, development and utilization of natural flavonoid compounds, semi-synthesis of natural flavonoid compounds with wide distribution, high content and low activity into flavonoid compounds, drugs or lead compounds with low content and stronger physiological activity is a rational utilization of natural flavonoid compound resources. At the same time, it has the advantages of fewer synthesis steps and low production cost, which is of great significance to the industrial development of flavonoid compounds.

[0004] Breast cancer is one of the most common malignant tumors in women, and its incidence rate ranks among the top among malignant tumors in women. According to the different receptor types, breast cancer can be divided into four subtypes: Luminal A, Luminal B, HER2 overexpression and triple-negative. Among them, triple-negative breast cancer (TNBC) lacks the expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2), accounting for 15% to 20% of all breast cancer types. However, due to its high malignancy, strong invasiveness, easy recurrence, easy metastasis and poor prognosis, it is considered to be the most dangerous type of breast cancer. Therefore, it is of great research significance to discover drugs with anti-triple-negative breast cancer activity and find corresponding targets. Flavonoids have a wide range of biological activities, among which anti-tumor activity has been reported more frequently, and they may become drugs or lead compounds against triple-negative breast cancer.

[0005] The invention uses hesperidin as a raw material to semi-synthesize its derivatives, and conducts an in vitro anti-human triple-negative breast cancer activity experiment. Summary of the invention

[0006] The purpose of the present invention is to explore the semi-synthesis of hesperidin derivatives using hesperidin as a raw material, and to find out the possible anti-triple-negative breast cancer drugs or lead compounds.

[0007] The technical solution of the present invention to solve the above technical problems is as follows:

[0008] Using hesperidin as raw material, benzyl-protected flavonol aglycones were synthesized through selective methylation, oxidation, benzylation and other reaction steps (the synthetic route is shown in the attached figure). Figure 1 As shown), then in DMF / K 2 CO 3 Under the conditions, the glycoside condensation reaction is carried out with fully acetylated brominated sugar, and finally the flavonoid glycoside is synthesized by debenzylation and acetyl reaction (the synthetic route is shown in the attached figure). Figure 2 A total of 32 flavonoid compounds were synthesized, including 14 flavonoid aglycones and 18 flavonoid glycosides, of which 15 were known compounds and 17 were new compounds (the structures are shown in Table 1).

[0009] Preparation method of brominated 2,3,4,6-tetra-O-acetyl-α-D-glucose 1p and brominated 2,3,4,6-tetra-O-acetyl-α-D-galactose 1s: firstly, all the hydroxyl groups of glucose or galactose are acetylated, and then the anomeric carbon of the acetyl sugar is brominated under the condition of red phosphorus and bromine, and then the one-pot synthesis is carried out (the synthetic route is shown in the attached Figure 3 With attached Figure 4 shown).

[0010] Table 1 Intermediates and target compounds (compounds marked with * are not reported)

[0011]

[0012]

[0013]

[0014]

[0015]

[0016]

[0017]

[0018] BRIEF DESCRIPTION OF THE DRAWINGS

[0019] Figure 1 The synthetic route of flavonoid aglycones

[0020] Figure 2 The synthetic route of flavonoid glycosides

[0021] Figure 3 The synthetic route of brominated 2,3,4,6-tetra-O-acetyl-α-D-glucose

[0022] Figure 4 The synthetic route of brominated 2,3,4,6-tetra-O-acetyl-α-D-galactose DETAILED DESCRIPTION

[0023] The present invention will be further described below in conjunction with the embodiments.

[0024] Example 1

[0025] Synthesis of compound 1a

[0026] Hesperidin (3.5 g, 11.6 mmol) was dissolved in 350 mL of dry anhydrous acetone, and anhydrous potassium carbonate (1.6 g, 11.6 mol) was added. After heating under reflux and stirring for 1.5 h, iodomethane (1.0 mL, 15.4 mmol) was slowly added dropwise, and the mixture was heated under reflux for 17 h. The anhydrous potassium carbonate was filtered off and the acetone was evaporated to obtain 3.8 g of a crude yellow powder. After silica gel column chromatography (cyclohexane / ethyl acetate = 2:1, volume ratio, the rest was the same), yellow needle-shaped solid 1a (2.75 g, yield 75.5%) and compound 2a (206 mg, yield 5.6%) were obtained.

[0027] Compound 1a: mp 161-162°C; 1 H-NMR (DMSO-d 6, 600 MHz) δ: 12.10 (s, 1H, 5-OH), 9.10 (s, 1H, 3′-OH), 6.93 (d, J = 6.0, 1H, H-5′), 6.92 (s, 1H, H-2′), 6.86 (dd, J = 8.4, 1.8 Hz, 1H, H-6′), 6.10 (d, J = 1.8 Hz, 1H, H-6), 6.07 (d, J = 2.4 Hz, 1H, H-8), 5.48 (dd, J = 12.6, 3.0 Hz, 1H, H-2), 3.78 (s, 3H, 7-OCH 3 ), 3.76 (s, 3H, 4′-OCH 3 ), 3.24 (dd, J = 16.2, 12.0 Hz, 1H, H-3b), 2.72 (dd, J = 17.4, 3.0 Hz, 1H, H-3a). 13 C-NMR (DMSO-d 6 , 150 MHz) δ: 196.8 (C-4), 167.4 (C-7), 163.2 (C-5), 162.7 (C-9), 147.9 (C-4), 146.5 (C-3), 131.0 (C-1′), 117.7 (C-6′), 114.1 (C-5′), 111.9 (C-2′), 102.6 (C-10), 94.6 (C-6), 93.8 (C-8), 78.4 (C-2), 55.9 (7-OCH 3 ), 55.7 (4′-OCH 3 ), 42.1 (C-3); ESI-MS m / z: 315 [M-H] - , 317 [M + H] + .

[0028] Compound 2a: m.p. 163 - 164 °C; 1 H-NMR (DMSO-d 6 , 600 MHz) δ: 12.09 (s, 1H, 5-OH), 7.11 (d, J = 1.8 Hz, 1H, H-5′), 7.01 (dd, J = 7.8, 1.8 Hz, 1H, H-2′), 6.95 (d, J = 7.8 Hz, 1H, H-6′), 6.10 (d, J = 1.8 Hz, 1H, H-6), 6.06 (d, J = 2.4 Hz, 1H, H-8), 5.51 (dd, J = 12.6, 3.0 Hz, 1H, H-2), 3.76 (s, 3H, 7-OCH 3 ), 3.74 (s, 3H, 4-OCH 3 ), 3.73 (s, 3H, 4′-OCH 3), 3.36 (t, J=17.4Hz, 1H, H-3b), 2.74 (dd, J=17.4, 3.0Hz, 1H, H-3a). 13 C-NMR (DMSO-d 6 , 150MHz) δ: 196.9(C-4), 167.5(7-C), 163.2(C-5), 162.8(C-9), 149.1(C-4), 148.7(C-3), 130.8(C-1′), 119.3(C-6′), 111.5(C-5′), 110.6(C-2′), 102.6(C-10), 94.7(C-6), 93.9(C-8), 78.7(2-C), 56.0(4′-OCH 3 ), 55.6(2C,7,3′-OCH 3 ), 42.2(3-C); ESI-MS m / z: 329[MH] - , 331[M+H] + .

[0029] Example 2

[0030] Synthesis of compound 1b

[0031] Compound 1a (2.5 g, 7.9 mmol) was dissolved in 40 mL of dry pyridine, and iodine (2.4 g, 7.5 mmol) was added. The reaction was carried out at 90 °C. The reaction progress was tracked by TLC. The reaction was stopped when the raw material point disappeared. After cooling to room temperature, ice water was slowly added under vigorous stirring to precipitate a brown-black solid. The filter cake was filtered and washed with 3% dilute hydrochloric acid until there was no pyridine smell. Unreacted iodine was removed with saturated sodium thiosulfate, and the crude yellow product was dried. The yellow needle crystals (2.0 g) were recrystallized from anhydrous ethanol, with a yield of 93.9%. mp 162~163 °C; 1 H-NMR (DMSO-d 6 , 600MHz) δ: 12.92 (s, 1H, 5-OH), 9.44 (s, 1H, 3′-OH), 7.56 (dd, J=8.4, 2.4Hz, 1H, H-6′), 7.45 (d, J=2.4Hz, 1H, H-2′), 7.0 9 (d, J=8.4Hz, 1H, H-5′), 6.81 (s, 1H, 3-H), 6.75 (d, J=1.8Hz, 1H, H-8), 6.37 (d, 1H, J=2.4Hz, H-6), 3.86 (s, 6H, 7, 4′-OCH 3 ). 13 C-NMR (DMSO-d 6, 150MHz) δ: 181.9(C-4), 165.2(C-2), 163.9(C-7), 161.2(C-5), 157.3(C-9), 151.3(C-4′), 146.8(C-3′), 122.9( C-1′), 118.8(C-6′), 113.1(C-2′), 112.1(C-5′), 104.7(C-10), 103.7(C-3), 98.0(C-6), 92.7(C-8), 56.1(4′-OCH 3 ), 55.8(7-OCH 3 ); ESI-MS m / z: 313[MH] - , 315[M+H] + .

[0032] Example 3

[0033] Synthesis of compound 1c

[0034] Hesperidin (5.0 g, 15.8 mmol) was dissolved in 80 mL of dry pyridine, and then iodine (4.8 g, 15 mmol) was added. The reaction was carried out at 90 ° C. The reaction progress was tracked by TLC. The reaction was stopped when the raw material point disappeared. After cooling to room temperature, ice water was slowly added under vigorous stirring to precipitate a brown-black solid. The filter cake was filtered and washed with 3% dilute hydrochloric acid until there was no pyridine smell. Unreacted iodine was removed with saturated sodium thiosulfate, and dried to obtain a yellow crude product. Recrystallization from anhydrous ethanol gave 4.5 g of yellow powder with a yield of 90.5%. mp 254~255 ° C; 1 H-NMR (DMSO-d 6 , 600MHz) δ: 12.73 (s, 1H, 5-OH) 7.46 (s, 1H, H-2′), 7.23 (d, J=8.4Hz, 1H, 6′-H), 6.92 (d, J= 8.4Hz, 1H, H-5′), 6.30 (s, 1H, H-3), 5.92 (s, 1H, H-8), 5.55 (s, 1H, H-6), 3.79 (3H, s, 4′-OCH 3 ). 13 C-NMR (DMSO-d 6 , 150MHz) δ: 179.1(C-4), 177.4(C-2), 161.1(C-7), 161.0(C-5), 158.3(C-9), 150.7(C-4′), 149.2(C-3′), 124.0( C-1′), 115.7(C-6′), 112.7(C-2′), 112.0(C-5′), 102.7(C-10), 102.1(C-3), 98.7(C-6), 96.7(C-8), 55.5(4′-OCH3 ); ESI-MS m / z: 299 [MH] - , 301[M+H] + .

[0035] Example 4

[0036] Synthesis of compound 1d

[0037] The first synthesis route:

[0038] Compound 1c (2.0 g, 6.67 mmol) was dissolved in 350 mL of dry anhydrous acetone, and anhydrous potassium carbonate (2.0 g, 14.5 mol) was added. The mixture was heated under reflux and stirred for 1.5 h, and then iodomethane (1.3 mL, 20.0 mmol) was slowly added dropwise. The mixture was heated under reflux for 17 h, and the anhydrous potassium carbonate was filtered off. The acetone was evaporated to obtain 2.5 g of a crude yellow powder. The mixture was chromatographed on a silica gel column (cyclohexane / ethyl acetate = 2:1) to obtain 1.9 g of a yellow powder with a yield of 87%.

[0039] The second synthesis route:

[0040] Compound 2a (200 mg, 0.6 mmol) was dissolved in 5 mL of dry pyridine, and iodine (200 mg, 0.62 mmol) was added. The reaction was carried out at 90 °C. The reaction progress was tracked by TLC. The reaction was stopped when the raw material point disappeared. After cooling to room temperature, ice water was slowly added under vigorous stirring to precipitate a brown-black solid. The filter cake was filtered and washed with 3% dilute hydrochloric acid until there was no pyridine smell. Unreacted iodine was removed with saturated sodium thiosulfate. The crude product was dried and recrystallized from anhydrous ethanol to obtain 160 mg of yellow powder with a yield of 84%. mp 164-165 °C; 1 H-NMR (DMSO-d 6 , 600MHz) δ: 12.90 (s, 1H, 5-OH), 7.72 (dd, J=8.4, 1.8Hz, 1H, H-6′), 7.58 (d, J=1.8Hz, 1H, H-2′), 7.14 (d, J=9 .0Hz, 1H, H-5′), 7.03 (s, 1H, H-3), 6.81 (d, J=2.4Hz, 1H, H-8), 6.38 (d, J=1.8Hz, 1H, H-6), 3.89 (3H, s, 4′-OCH 3 ), 3.88(s, 3H, 3′-OCH 3 ), 3.86(s, 3H, 7-OCH 3 ). 13 C-NMR (DMSO-d 6, 150MHz) δ: 182.0(C-4), 165.2(C-2), 163.6(C-7), 161.1(C-5), 157.3(C-9), 152.2(C-4′), 149.0(C-3′), 122.7( C-1′), 120.1(C-6′), 111.6(C-5′), 109.4(C-2′), 104.7(C-10), 104.0(C-3), 98.0(C-6), 92.7(C-8), 56.1(7-OCH 3 ), 55.9(4′-OCH 3 ), 55.7(3′-OCH 3 ); ESI-MS m / z: 327[MH] - , 329[M+H] + .

[0041] Example 5

[0042] Synthesis of compound 1e

[0043] Compound 1b (2.0 g, 9.3 mmol) was dissolved in 100 mL of dry anhydrous acetone, and anhydrous potassium carbonate (13.0 g, 94.2 mmol) was added. The mixture was heated to reflux and stirred for 1.5 h, and then benzyl bromide (2.6 mL, 20.0 mmol) was slowly added dropwise. The reflux reaction was continued. The reaction progress was tracked by TLC. The reaction was stopped when the raw material point disappeared. The mixture was cooled to room temperature, potassium carbonate was filtered out, and the solvent was recovered under reduced pressure to obtain a yellow crude product. 2.1 g of yellow powder was obtained by silica gel column chromatography (cyclohexane / ethyl acetate = 2:1). The yield was 67.8%. 1 H-NMR (DMSO-d 6 , 600MHz) δ: 7.29-7.66 (m, 12H, 5, 3′-Bn-Ar, H-2′, H-6′), 7.12 (d, J=14.4Hz, 1H, 5′-H), 6.85 (d, J =2.4Hz, 1H, H-8), 6.73 (s, 1H, H-3), 6.59 (d, J = 1.8Hz, 1H, H-6), 5.22 (d, J = 4.2Hz, 4H, 5, 3'-Bn-CH 2 ), 3.88(s, 3H, 4′-OCH 3 ), 3.84(s, 3H, 7-OCH 3 ). 13 C-NMR (DMSO-d 6, 150MHz) δ: 175.7 (C-4), 163.5 (C-2), 159.7 (C-7), 159.1 (C-5), 158.9 (C-9), 151.9 (C-4′), 148.0 (C-3′), 126.9-136.9 (12C, 5, 3′-O- Bn-Ar), 123.0(C-1′), 119.7(C-6′), 111.9(C-2′), 110.8(C-5′), 108.7(C-10), 107.1(C-3), 97.7(C-6), 93.7(C-8), 70.2(3′-O-Bn-CH 2 ), 69.8(7-O-Bn-CH 2 ), 56.0(4′-OCH 3 ), 55.8(7-OCH 3 ); ESI-MS m / z: 493[MH] - , 495[M+H] + .

[0044] Example 6

[0045] Synthesis of compound 1f

[0046] Compound 1d (2.0 g, 5.89 mmol) was dissolved in 100 mL of anhydrous acetone, and anhydrous potassium carbonate (8.0 g, 58.0 mmol) was added. After stirring at reflux for 1 h, benzyl bromide (1.0 mL, 7.7 mmol) was slowly added dropwise. The mixture was heated to reflux and the reaction progress was monitored by TLC. The reaction was stopped when the raw material point disappeared. The mixture was cooled to room temperature, potassium carbonate was filtered out, and the solvent was recovered under reduced pressure to obtain a yellow crude product. The product was purified by silica gel column chromatography (cyclohexane / ethyl acetate = 2:1) to obtain 1.8 g of a light yellow powder with a yield of 71.8%. 1 H-NMR (DMSO-d 6 , 600MHz) δ: 7.66 (dd, J=1.8Hz, 1H, H-6′), 7.62 (d, J=1.8Hz, 2H, H-2′, Bn-Ar), 7.31-7.43 (m, 4H, Bn-Ar), 7.12 (d, J=8.4Hz, 1H, H-5′), 6.89 (d, J=1.8Hz, 1H, H-8), 6.76 (s, 1H, H-3), 6.61 (d, J=2.4Hz, 1H, 6-H), 5.24 (s, 2H, 5-Bn-CH 2 ), 3.90(s, 3H, 4′-OCH 3 ), 3.89(3H, s, 3′-OCH 3 ), 3.85(3H, s, 7-OCH 3 ). 13C-NMR (DMSO-d 6 , 150MHz) δ: 175.7(C-4), 163.5(C-2), 159.7(C-7), 159.1(C-5), 158.9(C-9), 151.6(C-4′), 149.0(C-3′), 126.8-136.9(6C, Bn- Ar-C), 123.1(C-1′), 119.4(C-6′), 111.6(C-2′), 109.1(C-5′), 108.7(C-10), 107.1(C-3), 97.7(C-6), 93.7(C-8), 69.8(Bn-CH 2 ), 56.0(4′-OCH 3 ), 55.9(3′-OCH 3 ), 55.7(7-OCH 3 ); ESI-MS m / z: 417[MH] - , 419[M+H] + .

[0047] Example 7

[0048] Synthesis of compound 1g

[0049] Compound 1c (2.4 g, 7.9 mmol) was dissolved in 100 mL of dry acetone, and anhydrous potassium carbonate (11 g, 80 mmol) was added. After heating and reflux with stirring for 1 h, benzyl bromide (3.3 mL, 25 mmol) was slowly added dropwise, and the reaction was continued with stirring and reflux. The reaction progress was tracked by TLC. The reaction was stopped when the raw material point disappeared. The reaction was cooled to room temperature, potassium carbonate was filtered off, and acetone was evaporated to obtain a yellow crude product. After silica gel column chromatography (cyclohexane / ethyl acetate = 2:1), 3.0 g of yellow solid was obtained, with a yield of 65%. mp 153-154°C; 1 H-NMR (DMSO-d 6 , 600MHz) δ: 7.31-7.66 (m, 17H, 5, 7, 3′-Bn-Ar, H-2′, H-6′), 7.16 (d, J=9.6Hz, 1H, H-5′), 7.0 0 (d, J=1.8Hz, 1H, H-8), 6.75 (s, 1H, H-3), 6.71 (d, J=1.8Hz, 1H, H-6), 5.26 (s, 2H, 3′-O-Bn-CH 2 ), 5.25(s, 2H, 7-O-Bn-CH 2 ), 5.24 (s, 2H, 5-O-Bn-CH 2 ), 3.87(s, 3H, 4′-OCH 3 ). 13 C-NMR (DMSO-d6 , 150MHz) δ: 175.6 (C-4), 162.5 (C-2), 159.6 (C-7), 159.0 (2C, C-5, C-9), 151.9 (C-4′), 148.0 (C-3′), 123.6-136.8 (18C, Bn-Ar-C ), 123.0(C-1′), 119.7(C-6′), 112.0(C-2′), 110.8(C-5′), 108.8(C-10), 107.1(C-3), 94.6(C-6), 91.1(C-8), 70.2(3′-O-Bn-CH 2 ), 70.0(7-O-Bn-CH 2 ), 69.8(5-O-Bn-CH 2 ), 55.8(4′-OCH 3 ); ESI-MS m / z: 569[MH] - , 571[M+H] + .

[0050] Example 8

[0051] Synthesis of compound 1h

[0052] Compound 1e (1.6 g, 3.2 mmol) was dissolved in 140 mL of a mixed solvent of dichloromethane / acetone (v / v = 4:3), and 200 mL of Na 2 CO 3 / NaHCO 3 Buffer solution (Na 2 CO 3 8.0 g, NaHCO 3 3.8g), vigorously stirred at room temperature, and slowly added potassium persulfate complex salt solution (12g, 140mL) with a constant pressure funnel, and the dripping was completed in 6h. After reacting for 21h, 140mL of potassium persulfate complex salt solution (12g, 140mL) was slowly added dropwise, and the dripping was completed in about 6h. TLC was monitored until the raw material point disappeared, and the reaction was stopped. The organic phase was allowed to stand and separated, and the aqueous phase was extracted with dichloromethane (100mL×2). The organic phases were combined, and the organic phases were washed with saturated sodium thiosulfate (100mL×2) and saturated brine (100mL×2), respectively. The organic phase was dried over anhydrous sodium sulfate, filtered, 6mg of p-toluenesulfonic acid was added to the filtrate, and the reaction was continued at room temperature for 2h. The solvent was evaporated to dryness to obtain a brown crude product, which was recrystallized from dichloromethane / methanol to obtain 1.0g of yellow powder with a yield of 62.0%. 1 H-NMR (DMSO-d 6, 600MHz) δ: 9.16 (s, 1H, 3-OH), 7.31-7.87 (m, 12H, 5, 3′-O-Bn-Ar, H-2′, H-6′), 7.15 (d, J=9.0 Hz, 1H, H-5′), 6.84 (d, J=1.8Hz, 1H, H-8), 6.61 (d, J=2.4Hz, 1H, H-6), 5.26 (s, 2H, 3′-O-Bn-CH 2 ), 5.18 (s, 2H, 5-O-Bn-CH 2 ), 3.93(s, 3H, 4′-OCH 3 ), 3.86(s, 3H, 7-OCH 3 ). 13 C-NMR (DMSO-d 6 , 150MHz) δ: 171.2(C-4), 163.6(C-2), 158.8(C-7), 158.0(C-5), 150.3(C-9), 147.5(C-4′), 141.6(C-3′), 138.2(C-3), 126.6-136.9( 12C, 5, 3′-O-Bn-Ar), 123.5(C-1′), 121.2(C-6′), 112.3(C-2′), 111.8(C-5′), 106.6(C-10), 96.8(C-6), 93.1(C-8), 70.3(3′-O-Bn-CH 2 ), 69.8(5-O-Bn-CH 2 ), 56.0(4′-OCH 3 ), 55.6(7-OCH 3 ); ESI-MS m / z: 509[MH] - , 511[M+H] + .

[0053] Example 9

[0054] Synthesis of compound 1i

[0055] Compound 1f (1.5 g, 3.5 mmol) was dissolved in 140 mL of a mixed solvent of dichloromethane / acetone (v / v = 4:3), and 200 mL of Na 2 CO 3 / NaHCO 3 Buffer solution (8.0 g Na 2 CO 3 , 3.8 g NaHCO 3 , 200mL H 2O), stirred vigorously at room temperature, and 140 mL of potassium persulfate complex salt solution (12 g, 140 mL H 2 O), dripped for about 6 hours, reacted overnight, and then slowly added 140 mL of potassium persulfate complex salt solution (12 g, 140 mL H 2 O), about 2 hours of dripping, the raw material point disappeared, the reaction was stopped, the organic phase was separated by standing, the aqueous phase was extracted with dichloromethane (100mL×2), the organic phases were combined, and the organic phases were washed with saturated sodium thiosulfate (100mL×2) and saturated brine (100mL×2), respectively, the organic phase was dried over anhydrous sodium sulfate, filtered, 5 mg of p-toluenesulfonic acid was added to the filtrate, the reaction was carried out at room temperature for 2 hours, the solvent was evaporated to dryness, a brown solid was obtained, and dichloromethane / methanol was used to recrystallize to obtain 0.97 g of yellow powder with a yield of 60.4%. 1 H-NMR (DMSO-d 6 , 600MHz) δ: 9.14 (1H, s, 3-OH), 7.84 (dd, J=8.4, 1.8Hz, 1H, H-6′), 7.78 (d, J=1 .8Hz, 1H, H-2′), 7.70 (d, J=2.8Hz, 2H, 5-O-Bn-Ar), 7.42 (t, J=15.6Hz, 2H, 5-O -Bn-Ar), 7.33 (t, J=15.0Hz, 1H, 5-O-Bn-Ar), 7.147.70 (d, J=9.0Hz, 1H, H-5′) , 6.88 (d, J=1.8Hz, 1H, H-8), 6.61 (d, J=1.8Hz, 1H, H-6), 5.26 (s, 2H, 5-O-Bn-CH 2 ), 3.91(s, 3H, 4′-OCH 3 ), 3.85(s, 3H, 3′-OCH 3 ), 3.84 (3H, s, 7-OCH 3 ). 13 C-NMR (DMSO-d 6 , 150MHz) δ: 171.2(C-4), 163.6(C-2), 158.8(C-7), 158.0(C-5), 149.9(C-9), 148.4(C-4′), 141.8(C-3′), 138.1(C-3), 126.6-136. 9(6C,5-O-Bn-Ar), 123.6(C-1′), 120.8(C-6′), 111.5(C-2′), 110.5(C-5′), 106.6(C-10), 96.8(C-6), 93.1(C-8), 69.8(5-O-Bn-CH 2 ), 56.0(7-OCH 3), 55.7(4′-OCH 3 ), 55.6(3′-OCH 3 ); ESI-MS m / z: 433[MH] - , 435[M+H] + .

[0056] Example 10

[0057] Synthesis of compound 1j

[0058] Compound 1g (2.0g, 3.5mmol) was dissolved in 140mL of dichloromethane / acetone (v / v=4:3) mixed solvent, and 200mL of Na 2 CO 3 / NaHCO 3 Buffer solution (8.0 g Na 2 CO 3 , 3.8 g NaHCO 3 , 200mL H 2 O), stirred vigorously at room temperature, and 140 mL of potassium persulfate complex salt solution (12 g, 140 mL H 2 O), dripped for about 6 hours, reacted for 12 hours, and then slowly added 140 mL of potassium persulfate complex salt solution (12 g, 140 mL H 2 O), dripped for about 6 hours, the raw material point disappeared, stopped the reaction, stood to separate the organic phase, extracted the aqueous phase with dichloromethane (100mL×2), combined the organic phases, washed with saturated sodium thiosulfate (100mL) and saturated brine (100mL), dried over anhydrous sodium sulfate, filtered, added 5mg p-toluenesulfonic acid to the filtrate, reacted at room temperature for 2h, evaporated the solvent to obtain a brown oil, 1.2g of yellow powder recrystallized from anhydrous ethanol, yield 58.5%. mp159~160℃; 1 H-NMR (DMSO-d 6 , 600MHz) δ: 9.16 (s, 1H, 3-OH), 7.85 (s, 1H, H-2′), 7.30-7.68 (m, 16H, 7, 5, 3′-O-Bn-Ar, H-6′), 7. 16 (d, J=8.4Hz, 1H, H-5′), 6.96 (s, 1H, H-8), 6.70 (d, J=1.8Hz, 1H, H-6), 5.25 (s, 4H, 7, 3′-O-Bn-CH 2 ), 5.16(s, 2H, 5-O-Bn-CH 2 ), 3.84(s, 3H, 7-OCH 3 ). 13 C-NMR (DMSO-d6 , 150MHz) δ: 171.2(C-4), 162.7(C-2), 158.9(C-7), 157.9(C-5), 150.3(C-9), 147.5(C-4′), 141.7(C-3′), 138.2(C-3), 126.6-136.9(18 C, 5, 7, 3′-O-Bn-Ar-C), 123.5(C-1′), 121.2(C-6′), 112.2(C-2′), 111.9(C-5′), 106.7(C-10), 97.3(C-6), 94.0(C-8), 70.3(3′-O-Bn-CH 2 ), 70.1(7-O-Bn-CH 2 ), 69.8(5-O-Bn-CH 2 ), 55.7(4′-OCH 3 ); ESI-MS m / z: 585[MH] - , 587[M+H] + .

[0059] Embodiment 11

[0060] Synthesis of compound 1k

[0061] Compound 1h (51 mg, 0.1 mmol) was dissolved in 10 mL of methanol / tetrahydrofuran (v / v=1:1) mixed solvent, 10% Pd / C (90 mg) was added, and the mixture was reacted for 24 h in a hydrogen atmosphere at room temperature and pressure. Pd / C was removed by filtration, and the solvent was concentrated and recovered to obtain 25 mg of a yellow powder with a yield of 78%. 1 H-NMR (DMSO-d 6 , 600MHz) δ: 12.44 (s, 1H, 5-OH), 9.55 (br s, 1H, 3-OH), 9.32 (s, 1H, 3′-OH), 7.71 (d, J=2.4H, 1H, H-2′), 7.68 (dd, J=8.4, 1.8Hz, 1H, H-6′), 7.0 8 (d, J=8.4Hz, 1H, H-5′), 6.71 (d, J=1.8Hz, 1H, H-8), 6.34 (d, J=2.4Hz, 1H, H-6), 3.85 (s, 3H, 4′-OCH 3 ), 3.84(s, 3H, 7-OCH 3 ). 13 C-NMR (DMSO-d 6, 150MHz) δ: 176.1(C-4), 165.0(C-2), 160.4(C-7), 156.1(C-5), 149.4(C-9), 146.8(C-4′), 146.2(C-3′), 136.5( 3-C), 123.4(C-1′), 119.8(C-6′), 114.7(C-2′), 111.8(C-5′), 104.1(C-10), 97.5(C-6), 91.9(C-8), 56.0(4′-OCH 3 ), 55.6(7-OCH 3 ); ESI-MS m / z: 329[MH] - , 331[M+H] + .

[0062] Example 12

[0063] Synthesis of compound 1l

[0064] Compound 1i (50 mg, 0.12 mmol) was dissolved in 10 mL of methanol / tetrahydrofuran (v / v=1:1) mixed solvent, 10% Pd / C (90 mg) was added, and the mixture was reacted for 24 h in a hydrogen atmosphere at room temperature and pressure. Pd / C was removed by filtration, and the solvent was concentrated and recovered to obtain 34 mg of yellow powder with a yield of 85%. 1 H-NMR (DMSO-d 6 , 600MHz) δ: 12.40 (s, 1H, 5-OH), 9.64 (s, 1H, 3-OH), 7.84 (d, J=8.4Hz, 1H, H-6′) 7.75 (s, 1H, H -2′), 7.13(d, J=8.4Hz, 1H, H-5′), 6.78(s, 1H, H-8), 6.34(s, 1H, H-6), 3.84(s, 6H, 3′, 4′-OCH 3 ), 3.82(s, 3H, 7-OCH 3 ). 13 C-NMR (DMSO-d 6 , 150MHz) δ: 176.1(C-4), 165.0(C-2), 160.4(C-7), 156.2(C-5), 150.5(C-9), 148.4(C-4′), 146.6(C-3′), 1366(C -3), 123.2(C-1′), 121.6(C-6′), 111.5(C-2′), 110.9(C-5′), 104.1(C-10), 97.6(C-6), 92.2(C-8), 56.1(4′-OCH 3 ), 55.7(3′-OCH 3), 55.6(7-OCH 3 ); ESI-MS m / z: 323[MH] - , 325[M+H] + .

[0065] Embodiment 13

[0066] Synthesis of compound 1m

[0067] Compound 1j (50 mg, 0.08 mmol) was dissolved in 10 mL of methanol / tetrahydrofuran (v / v=1:1) mixed solvent, 10% Pd / C (90 mg) was added, and the mixture was reacted for 24 h in a hydrogen atmosphere at room temperature and pressure, Pd / C was removed by filtration, and the solvent was concentrated to obtain 23 mg of yellow powder with a yield of 84%. mp 143~144℃; 1 H-NMR (DMSO-d 6 , 600MHz) δ: 12.46 (s, 1H, 5-OH), 7.75 (d, J=7.2Hz, 1H, H-5′), 7.69 (dd, J=8.4, 1.8Hz, 1H, H-6′), 7.4 7 (d, J=1.8Hz, 1H, H-2′), 6.94 (d, J=1.8Hz, 1H, H-8), 6.19 (d, J=1.8Hz, 1H, H-6), 3.84 (s, 3H, 4′-OCH 3 ). 13 C-NMR (DMSO-d 6 , 150MHz) δ: 176.0(C-4), 165.0(C-2), 160.4(C-7), 156.2(C-5), 159.3(C-9), 146.3(C-4′), 146.2(C-3′), 136.1( C-3), 123.4(C-1′), 119.7(C-6′), 114.6(C-2′), 111.8(C-5′), 103.1(C-10), 98.2(C-6), 93.4(C-8), 55.6(4′-OCH 3 )ESI-MS m / z:315[MH] - , 317[M+H] + .

[0068] Embodiment 14

[0069] Synthesis of compound 1

[0070] Compound 1h (120 mg, 0.23 mmol) was dissolved in dry DMF (5 mL) and anhydrous K 2 CO 3(110 mg, 0.80 mmol), fully acetylated brominated glucose (186 mg, 0.46 mmol), reacted for 24 h under nitrogen protection at room temperature, quenched with 20 mL of ice water, then adjusted to neutral with 3% dilute hydrochloric acid, extracted with ethyl acetate (30 mL × 3), the organic layer was washed with saturated brine (100 mL × 2), anhydrous MgSO 4 The residue was dried, filtered and concentrated to obtain a yellow oil, which was purified by silica gel column chromatography (cyclohexane / ethyl acetate = 2:1) to obtain 112.6 mg of a yellow solid with a yield of 60.0%. 1 H-NMR (DMSO-d 6 , 600MHz) δ: 7.81 (d, J=1.8Hz, 1H, H-2′), 7.73 (dd, J=8.4, 2.4Hz, H-6′), 7. 63 (d, J=7.2Hz, H-2′), 7.32-7.63 (m, 10H, Bn-Ar), 7.13 (d, J=9.0Hz, 1H, H-5 ′), 6.80 (d, J=1.8Hz, 1H, H-8), 6.62 (d, J=2.4Hz, 1H, H-6), 5.72 (d, J=7.8Hz , 1H, H-1″), 5.43 (t, J=13.2Hz, 1H, H-6″), 5.24 (d, J=6.6Hz, 2H, 3′-O-Bn-CH 2 ), 5.20 (d, 2H, J=4.2Hz, 5-O-Bn-CH 2 ), 5.05(m, 1H, H-6″), 4.93(m, 1H, H-5″), 3.98(m, 2H, H-2″, H-3″), 3.89(s, 3H, 4′-OCH 3 ), 3.86(s, 3H, 7-OCH 3 ), 3.93-3.84(m, 1H, H-5″), 2.08(s, 3H, COCH 3 ), 1.95(s, 6H, CH 3 CO), 1.73(s, 3H, CH 3 CO); 13 C-NMR (DMSO-d 6, 150MHz) δ: 171.3 (C-4), 169.6, 169.5, 169.4, 169.3 (4C, Ac-CO×4), 163.8 (C-7 ), 159.1(C-2), 158.2(C-5), 153.4(C-9), 151.1(C-4′), 147.0(C-3′), 136.9(C -3), 127.0-136.7(10C, Bn-Ar), 122.4(C-1′), 122.2(C-6′), 113.8(C-2′), 111 .3(C-5′), 108.5(C-10), 98.3(C-1″), 97.5(C-6), 93.3(C-8), 71.7(3′-O-Bn-CH 2 ), 71.6(5-O-Bn-CH 2 ), 70.4(C-3″), 70.2(C-2″), 70.0(C-4″), 67.9(C-5″), 61.1(C-6″), 56.1(4′-OCH 3 ), 55.7(7-OCH 3 ), 20.6, 20.4, 20.3, 20.0 (4C, Ac-CH 3 ); ESI-MS m / z: 839[MH] - , 841[M+H] + .

[0071] Embodiment 15

[0072] Synthesis of compound 2

[0073] Compound 1i (100 mg, 0.23 mmol) was dissolved in dry DMF (5 mL) and anhydrous K 2 CO 3 (220 mg, 1.6 mmol), fully acetylated brominated glucose (186 mg, 0.46 mmol), reacted under nitrogen protection at room temperature for 24 h, quenched with 20 mL of ice water, then adjusted to neutral with 3% dilute hydrochloric acid, extracted with ethyl acetate (30 mL × 3), the organic layer was washed with saturated brine (100 mL × 2), anhydrous MgSO 4 The residue was dried, filtered and concentrated to obtain a yellow oil, which was purified by silica gel column chromatography (cyclohexane / ethyl acetate = 2:1) to obtain 116.0 mg of a white solid compound with a yield of 65.8%. 1 H-NMR (DMSO-d 6,600MHz)δ:7.76(d,J=1.8Hz,1H,H-2′),7.69(dd,J=9.0,2.4Hz,1H,H-6′),7.63(d,J=7.2Hz,2H,Bn-Ar),7.42(t,J=15.0Hz,2H,Bn-Ar),7.33(t,J=15Hz,1H,Bn-Ar),7.10(d,J=8.4Hz,1H,H-5′),6.85(d,J=2.4Hz,1H,H-8),6.62(d,J=2.4Hz,1H,H-6),5.74(d,J=7.8Hz,1H,H-1″),5.43(t,J=19.8Hz,1H,H-6″),5.24(d,J=6.6Hz,2H,5-O-Bn-CH 2 ),5.02(m,1H,H-6″),4.90(m,1H,H-5″),3.99(m,1H,H-2″,H-3″),3.89(s,3H,4′-OCH 3 ),3.88(s,3H,3′-OCH 3 ),3.84(s,3H,7-OCH 3 ),3.82(m,1H,H-5″),2.07(s,3H,CH 3 CO),1.96(s,3H,CH 3 CO),1.95(s,3H,CH 3 CO),1.79(s,3H,CH 3 CO); 13 C-NMR(DMSO-d 6 ,150MHz)δ:171.3(C-4),169.6,169.5,169.4,169.3(4C,Ac-CO),163.8(C-7),159.1(C-2),158.2(C-5),153.4(C-9),150.8(C-4′),147.9(C-3′),136.7(C-3),127.0-135.3(5C,5-O-Bn-Ar),122.3(C-1′),121.8(C-6′),112.2(C-2′),111.0(C-5′),108.5(C-10),98.4(C-1″),97.5(C-6),93.4(C-8),71.7(5-O-Bn-CH 2 ),71.6(C-3″),70.4(C-2″),70.0(C-4″),67.8(C-5″),61.0(C-6″),56.1(4′-OCH 3 ),55.6(3′-OCH 3), 55.5(7-OCH 3 ), 20.5, 20.4, 20.3, 20.0 (4C, Ac-CH 3 ); ESI-MS m / z: 763[MH] - , 765[M+H] + .

[0074] Example 16

[0075] Synthesis of compound 3

[0076] Compound 1j (180 mg, 0.32 mmol) was dissolved in dry DMF (10 mL) and K 2 CO 3 (330 mg, 2.4 mmol), fully acetylated brominated glucose (260 mg, 0.64 mmol), reacted for 24 h under nitrogen protection at room temperature, and then 30 mL of H 2 O, then adjusted to neutral with 3% dilute hydrochloric acid, extracted with ethyl acetate (40 mL × 3), washed with saturated brine (100 mL × 2), and anhydrous MgSO 4 The residue was dried, filtered and concentrated to obtain a yellow oil, which was purified by silica gel column chromatography (cyclohexane / v ethyl acetate = 2:1) to obtain 148.5 mg of a light yellow solid with a yield of 53.4%. 1 H-NMR (DMSO-d 6 , 600MHz) δ: 7.82 (d, J=2.4Hz, 1H, H-2′), 7.72 (dd, J=8.4, 2.4Hz, 1H, H-6′), 7.62 (d, J=7.2 Hz, 2H, Bn-Ar), 7.52 (d, J=7.2Hz, 2H, Bn-Ar), 7.49 (d, J=7.2Hz, 2H, Bn-Ar), 7.32-7.44 (m, 9H, Bn-Ar), 7.14 (d, J=9.0Hz, 1H, H-5′), 6.94 (d, J=2.4Hz, 1H, H-8), 6.73 (d, J=1.8Hz, 1H, H-6), 5.74 (d, J=7.8Hz, 1H, H-1″), 5.44 (t, J=19.2Hz, 1H, H-6″), 5.25 (m, 4H, 7, 3′-O-Bn-CH 2 ), 5.20 (d, J=7.8Hz, 2H, 5-O-Bn-CH 2 ), 5.04-5.07 (m, 1H, H-6″), 4.91-4.95 (m, 1H, H-5″), 3.94-3.98 (m, 2H, H-2″, H-3″), 3.86 (s, 3H, 4′-OCH 3), 3.81-3.84(m, 1H, H-4″), 2.08(s, 3H, CH 3 CO), 1.96(s, 6H, CH 3 CO), 1.73(s, 3H, CH 3 CO); 13 C-NMR (DMSO-d 6 , 150MHz) δ: 171.3 (C-4), 169.6, 169.5, 169.4, 169.3 (4C, Ac-CO), 162.8 (C-7), 15 9.1(C-2), 158.1(C-5), 153.4(C-9), 151.2(C-4′), 147.0(C-3′), 136.85(C-3), 1 26.9-136.7(15C, Bn-Ar), 122.4(C-1′), 122.2(C-6′), 113.8(C-2′), 111.3(C-5′ ), 108.6(C-10), 98.3(C-1″), 97.9(C-6), 94.2(C-8), 71.7, 71.6, 70.4(3C, Bn-CH 2 ), 70.2(C-3″), 70.1(C-2″), 70.0(C-4″), 67.9(C-6″), 61.1(C-5″), 55.7(4′-OCH 3 ), 20.6, 20.4, 20.3, 20.0 (4C, Ac-CH 3 ); ESI-MS m / z: 915[MH] - , 917[M+H] + .

[0077] Embodiment 17

[0078] Synthesis of compound 4

[0079] Compound 1h (100 mg, 0.20 mmol) was dissolved in dry DMF (5 mL) and anhydrous K 2 CO 3 (193 mg, 1.4 mmol), fully acetylated brominated galactose (160 mg, 0.40 mmol), reacted under nitrogen protection at room temperature for 24 h, quenched with 20 mL of ice water, extracted with ethyl acetate (30 mL × 3), the organic layer was washed with saturated brine (100 mL × 2), anhydrous MgSO 4 The residue was dried, filtered and concentrated to obtain a yellow oil, which was purified by silica gel column chromatography (cyclohexane / ethyl acetate = 2:1) to obtain 108.0 mg of a light yellow solid with a yield of 69.0%. 1 H-NMR (DMSO-d 6,600MHz)δ:7.95(d,J=2.4Hz,1H,H-2′),7.72(dd,J=8.4,1.8Hz,1H,H-6′),7.63(d,J=7.8Hz,2H,Bn-Ar),7.53(d,J=7.2Hz,2H,Bn-Ar),7.32-7.43(m,6H,Bn-Ar),7.10(d,J=9.0Hz,1H,H-5′),6.81(d,J=1.8Hz,1H,H-8).6.61(d,J=2.4Hz,1H,H-6),5.69(d,J=7.8Hz,1H,H-1″),5.26-5.36(m,2H,H-3″,H-5″),5.23(d,J=1.8Hz,2H,3′-O-Bn-CH 2 ),5.18-5.20(m,3H,5-O-Bn-CH 2 ,H-2″),4.19-4.21(t,J=12.6Hz,1H,H-4″),3.92-4.03(m,1H,H-6″),3.89(s,3H,4′-OCH 3 ),3.85(s,3H,7-OCH 3 ),3.80-3.84(m,1H,H-6″),2.10(s,3H,CH 3 CO),1.92(s,3H,CH 3 CO),1.79(s,3H,CH 3 CO),1.75(s,3H,4′-OCH 3 )。 13 C-NMR(DMSO-d 6 ,150MHz)δ:171.4(C-4),169.8,169.7,169.6,169.42(4C,Ac-CO),163.8(C-7),159.1(C-2),153.0(C-5),151.2(C-4′),147.0(C-3′),136.9(C-3),127.0-136.7(12C,Bn-Ar),122.3(C-1′),122.0(C-6′),114.0(C-2′),111.3(C-5′),108.5(C-10),98.9(C-1″),97.5(C-6),93.3(C-8),70.2(7-O-Bn-CH 2 ),70.0(2C,5,4′Bn-CH 2 ),70.0(2C,C-2″,C-3″),69.2(C-4″),67.2(C-5″),60.7(C-6″),56.1(4′-OCH3 ), 55.7(7-OCH 3 ), 20.7, 20.4, 20.2, 19.9 (4C, Ac-CH 3 ); ESI-MS m / z: 839[MH] - , 841[M+H] + .

[0080] Embodiment 18

[0081] Synthesis of compound 5

[0082] Compound 1i (100 mg, 0.23 mmol) was dissolved in dry DMF (5 mL) and anhydrous K 2 CO 3 (220 mg, 1.6 mmol), fully acetylated brominated galactose (186 mg, 0.46 mmol), reacted under nitrogen protection at room temperature for 24 h, quenched with 20 mL of ice water, then adjusted to neutral with 3% dilute hydrochloric acid, extracted with ethyl acetate (30 mL × 3), the organic layer was washed with saturated brine (100 mL × 2), anhydrous MgSO 4 The residue was dried, filtered and concentrated to obtain a yellow oil, which was purified by silica gel column chromatography (cyclohexane / ethyl acetate = 2:1) to obtain 112.7 mg of a white solid with a yield of 64.0%. 1 H-NMR (DMSO-d 6 , 600MHz) δ: 7.91 (d, J=1.8Hz, 1H, H-2′), 7.65 (dd, J=8.4, 1.8Hz, 1H, H-6′), 7.60 (d, J=7.2Hz, 2H, Bn-Ar), 7.42 (t, J=8.4Hz, 2H, Bn-Ar), 7.33 (t, J=15Hz, 1H, Bn-Ar) ), 7.07 (d, J = 8.4Hz, 1H, H-5′), 6.84 (d, J = 1.8Hz, 1H, H-8), 6.60 (d, J = 1.8Hz, 1H, H -6), 5.70 (d, J=8.4Hz, 1H, H-1″), 5.33 (m, 1H, H-5″), 5.15-5.22 (m, 5H, 5-O-Bn-CH 2 , H-2″, H-3″, H-4″), 4.19(m, 2H, H-6″), 3.91(s, 3H, 4′-OCH 3 ), 3.87(s, 3H, 3′-OCH 3 ), 3.83(s, 3H, 7-OCH 3 ), 2.08(s,6H,CH 3 CO), 1.92(s, 3H, CH 3CO), 1.75(s, 3H, CH 3 CO); 13 C-NMR (DMSO-d 6 , 150MHz) δ: 171.3 (C-4), 169.9, 169.6, 169.6, 169.5 (4C, Ac-CO), 163.8 (C-7) , 159.1(C-2), 158.2(C-5), 153.2(C-9), 150.8(C-4′), 147.8(C-3′), 136.8(C- 3), 127.0-135.3(5C, Bn-Ar), 122.33(C-1′), 121.3(C-6′), 112.4(C-2′), 111 .0(C-5′), 108.5(C-10), 98.8(C-1″), 97.5(C-6), 93.3(C-8), 70.3(5-O-Bn-CH 2 ), 70.0(C-2″), 69.9(C-3″), 69.1(C-4″), 67.2(C-5″), 60.7(C-6″), 56.1(4′-OCH 3 ), 55.7(3′-OCH 3 ), 55.5(7-OCH 3 ), 20.7, 20.4, 20.3, 20.2 (4C, Ac-CH 3 ); ESI-MS m / z: 763[MH] - , 765[M+H] + .

[0083] Embodiment 19

[0084] Synthesis of compound 6

[0085] Compound 1j (200 mg, 0.36 mmol) was dissolved in dry DMF (10 mL) and K 2 CO 3 (350 mg, 2.54 mmol), fully acetylated brominated galactose (290 mg, 0.71 mmol), reacted for 24 h under nitrogen protection at room temperature, and then 30 mL of H 2 O, then adjusted to neutral with 3% dilute hydrochloric acid, extracted with ethyl acetate (40 mL × 3), washed with saturated brine (100 mL × 2), and anhydrous MgSO 4 The residue was dried, filtered and concentrated to obtain a yellow oil, which was purified by silica gel column chromatography (cyclohexane / ethyl acetate = 2:1) to obtain 182 mg of a white solid with a yield of 65.5%. 1 H-NMR (DMSO-d 6,600MHz)δ:7.96(s,1H,H-2′),7.72(dd,J=8.4,1.8Hz,1H,H-6′),7.62(d,J=7.2Hz,2H,Bn-Ar),7.53(d,J=7.2Hz,2H,Bn-Ar),7.47(d,J=7.2Hz,2H,Bn-Ar),7.30-7.42(m,9H,Bn-Ar),7.12(d,J=9.0Hz,1H,H-5′),6.94(s,1H,H-8),6.70(s,1H,H-6),5.70(d,J=7.8Hz,1H,H-1″),5.26-5.35(m,2H,H-3″,H-5″),5.17-5.26(m,6H,5,3′-O-BnCH 2 ,H-2″,H-4″),4.19(t,J=13.2Hz,1H,H-6″),3.85(s,3H,4′-OCH 3 ),3.82-3.84(m,1H,H-6″),2.10(s,3H,CH 3 CO),1.92(s,3H,CH 3 CO),1.78(s,3H,CH 3 CO),1.74(s,3H,CH 3 CO); 13 C-NMR(DMSO-d 6 ,150MHz)δ:171.36(C-4),169.81,169.70,169.57,169.43(4C,Ac-CO),162.83(C-7),159.13(C-2),158.08(C-5),153.03(C-4′),151.20(C-3′),146.99(C-10),136.87(C-3),126.94-136.75(15C,Bn-Ar-C),122.32(C-1′),121.99(C-6′),114.03(C-2′),111.33(C-5′),108.60(C10),98.89(C-1″),97.92(C-6),94.19(C-8),70.2(5-O-Bn-CH 2 ),70.1(3′-O-Bn-CH 2 ),70.0(5-O-Bn-CH 2 ),70.0(C-2″),70.0(C-3″),69.2(C-4″),67.2(C-5″),60.7(C-6″),55.7(4′-OCH 3), 20.7, 20.4, 20.2, 19.9 (4C, Ac-CH 3 ); ESI-MS m / z: 915[MH] - , 917[M+H] + .

[0086] Embodiment 20

[0087] Synthesis of compound 7

[0088] Compound 1 (96 mg, 0.114 mmol) was dissolved in 10 mL of methanol / tetrahydrofuran (v / v=1:1) mixed solvent, 10% Pd / C (180 mg) was added, and the mixture was reacted for 24 h in a hydrogen atmosphere at room temperature and pressure. Pd / C was removed by filtration, and the solvent was concentrated and recovered to obtain 74 mg of a yellow oil with a yield of 98%. 1 H-NMR (DMSO-d 6 , 600MHz) δ: 12.49 (s, 1H, 5-OH), 9.41 (s, 1H, 3′-OH), 7.63 (d, J=2.4Hz, 1H, H-2′), 7.60 (dd, J= 8.4, 1.8Hz, 1H, H-6′), 7.06 (d, J=8.4Hz, 1H, H-5′), 6.74 (d, J=2.4Hz, 1H, H-8), 6.38 (d, J=2.4 Hz, 1H, H-6), 5.70 (d, J=7.8Hz, 1H, H-1″), 5.36 (t, J=19.2Hz, 1H, H-6″), 5.13 (t, J=17.4Hz, 1H , H-6″), 5.01 (t, J=19.2Hz, 1H, H-5″), 3.87-3.98 (m, 3H, H-2″, H-3″, H-4″), 3.85 (s, 3H, 4′-OCH 3 ), 3.84(s, 3H, 7-OCH 3 ), 2.02(s, 3H, CH 3 CO), 1.96(s, 3H, CH 3 CO), 1.95(s, 3H, CH 3 CO), 1.81(s, 3H, CH 3 CO); 13 C-NMR (DMSO-d 6, 150MHz) δ: 177.0 (C-4), 169.7, 169.5, 169.3, 169.3 (4C, Ac-CO), 165.4 (C-7), 160.8 ( C-2), 157.2(C-5), 156.3(C-9), 150.4(C-4′), 146.0(C-3′), 133.2(C-3), 121.9(C-1′) , 121.1(C-6′), 116.1(C-2′), 111.3(C-5′), 105.0(C-10), 98.6(C-1″), 98.1(C-6), 92. 4(C-8), 71.9(C-3″), 71.4(C-2″), 70.6(C-5″), 67.8(C-4″), 61.0(C-6″), 56.2(4′-OCH 3 ), 55.6(7-OCH 3 ), 20.5, 20.4, 20.3, 20.1 (4C, Ac-CH 3 ); ESI-MS m / z: 659[MH] - , 661[M+H] + .

[0089] Embodiment 21

[0090] Synthesis of compound 8

[0091] Compound 2 (90 mg, 0.118 mmol) was dissolved in 10 mL of methanol / tetrahydrofuran (v / v=1:1) mixed solvent, 10% Pd / C (180 mg) was added, and the mixture was reacted for 12 h in a hydrogen atmosphere at room temperature and pressure. Pd / C was removed by filtration, and the solvent was concentrated and recovered to obtain 78.8 mg of a yellow oil with a yield of 99%. 1 H-NMR (DMSO-d 6 , 600MHz) δ: 12.46 (s, 5-OH), 7.74 (d, J=2.4Hz, 1H, H-2′), 7.69 (dd, J=8.4, 1.8Hz, 1H, H -6'), 7.13 (d, J=9.0Hz, 1H, H-5'), 6.80 (d, J=1.8Hz, 1H, H-8), 6.40 (d, J=1.8Hz, 1H, H- 6), 5.72 (d, J=8.4Hz, 1H, H-1″), 5.38 (t, J=19.2Hz, 1H, H-6″), 5.02 (t, J=18.0Hz, 1H, H -6″), 4.90(t, J=17.8Hz, 1H, H-5″), 3.97-4.00(m, 2H, H-2″, H-3″), 3.88(s, 3H, 4′-OCH 3 ), 3.87(s, 3H, 3′-OCH3 ), 3.84(s, 3H, 7-OCH 3 ), 3.80-3.84(m, 1H, H-4″), 2.03, 1.95, 1.79(s, 12H, CH 3 CO); 13 C-NMR (DMSO-d 6 , 150MHz) δ: 176.7 (C-4), 169.4, 169.2, 169.1, 169.0 (4C, Ac-CO), 165.13 (C-7), 160.6 ( C-2), 156.8(C-5), 156.1(C-9), 151.1(C-4′), 147.6(C-3′), 133.0(C-3), 122.2(C-1′) , 121.6(C-6′), 112.0(C-2′), 110.8(C-5′), 104.8(C-10), 98.4(C-1″), 97.8(C-6), 92. 4(C-8), 71.4(C-3″), 71.1(C-2″), 70.4(C-5″), 67.4(C-4″), 60.7(C-6″), 55.9(4′-OCH 3 ), 55.4(3′-OCH 3 ), 55.3(7-OCH 3 ), 20.2, 20.1, 20.0, 19.8 (4C, Ac-CH 3 ); ESI-MS m / z: 673[MH] - , 675[M+H] + .

[0092] Embodiment 22

[0093] Synthesis of compound 9

[0094] Compound 3 (225 mg, 0.273 mmol) was dissolved in 10 mL of methanol / tetrahydrofuran (v / v=1:1) mixed solvent, 10% Pd / C (180 mg) was added, and the mixture was reacted for 24 h in a hydrogen atmosphere at room temperature and pressure. Pd / C was removed by filtration, and the solvent was concentrated and recovered to obtain 169 mg of a yellow oil with a yield of 96%. 1 H-NMR (DMSO-d 6, 600MHz) δ: 12.49 (s, 1H, 5-OH), 10.92 (br-s, 1H, 7-OH), 9.40 (s, 1H, 3′-OH), 7.57 (d, J=1.8Hz, 1H, H-2′) , 7.55 (dd, J=9.0, 2.4Hz, 1H, H-6′), 7.02 (d, J=8.4Hz, 1H, H-5′), 6.41 (d, J=1.8Hz1H, H-8), 6.19 (d, J=1. 8Hz, 1H, H-6), 5.66 (d, J=7.8Hz, 1H, H-1″), 5.34 (t, J=19.2Hz, 1H, H-6″), 5.11 (t, J=18.0Hz, 1H, H-6″), 4 .99(t, J=18.6Hz, 1H, H-5″), 3.91-3.95(m, 2H, H-2″, H-3″), 3.84-3.86(m, 1H, H-4″), 3.82(s, 3H, 4′-OCH 3 ), 2.00, 1.95, 1.94, 1.80(s, each 3H, CH 3 CO); 13 C-NMR (DMSO-d 6 , 150MHz) δ: 176.8 (C-4), 169.8, 169.5, 169.3, 169.3 (4C, Ac-CO), 164.4 (C-7), 161.2 ( C-2), 156.8(C-5), 156.4(C-9), 150.3(C-4′), 145.9(C-3′), 133.0(C-3), 122.0(C-1′) , 121.0(C-6′), 115.9(C-2′), 111.3(C-5′), 104.0(C-10), 98.8(C-1″), 98.6(C-6), 93. 8(C-8), 71.9(C-3″), 71.4(C-2″), 70.5(C-5″), 67.8(C-4″), 61.0(C-6″), 55.6(4′-OCH 3 ), 20.5, 20.4, 20.3, 20.1 (4C, Ac-CH 3 ); ESI-MS m / z: 645[MH] - , 647[M+H] + .

[0095] Embodiment 23

[0096] Synthesis of compound 10

[0097] Compound 4 (100 mg, 0.119 mmol) was dissolved in 10 mL of a mixed solvent of methanol / tetrahydrofuran (v / v=1:1), and 10% Pd / C (180 mg) was added. The mixture was reacted for 24 h in a hydrogen atmosphere at room temperature and pressure. The Pd / C was removed by filtration, and the solvent was concentrated and recovered to obtain 77 mg of a yellow oil with a yield of 98%. 1 H-NMR (DMSO-d 6 , 600MHz) δ: 12.47 (s, 1H, 5-OH), 9.22 (s, 1H, 3′-OH), 7.62 (dd, J=8.4, 2.4Hz, 1H, H-6′), 7.52 (d, J=1.8Hz, 1H, H-2′), 7.03 (d, J=8.4Hz, H-5′), 6.71 (d, J=2 .4Hz, 1H, H-8), 6.35 (d, J=1.8Hz, 1H, H-6), 5.61 (d, J=7.2Hz, 1H, H-1″), 5.22 -5.24(m,1H,H-5″),5.16-5.20(m,3H,H-2″,H-3″,H-,4″),3.84(s,3H,4′-OCH 3 ), 3.83(s, 3H, 7-OCH 3 ), 3.79-3.82(m, 2H, H-6″), 2.10(s, 3H, CH 3 CO), 2.02 (s, 3H, CH 3 CO), 1.90(s, 3H, CH 3 CO), 1.75(s, 3H, CH 3 CO); 13 C-NMR (DMSO-d 6 , 150MHz) δ: 177.1 (C-4), 169.9, 169.6, 169.5, 169.4 (4C, Ac-CO), 165.3 (C-7), 160.9 ( C-2), 157.2(C-5), 156.4(C-9), 150.4(C-4′), 146.0(C-3′), 133.3(C-3), 122.2(C-1′ ), 121.5(C-6′), 116.0(C-2′), 111.2(C-5′), 105.0(C-10), 98.9(C-1″), 98.1(C-6), 9 2.4(C-8), 70.2(2C, C-2″, C-3″), 69.2(C-4″), 67.1(C-5″), 60.9(C-6″), 56.2(4′-OCH 3 ), 55.7(7-OCH 3 ), 20.6, 20.4, 20.4, 20.2 (4C, Ac-CH 3); ESI-MS m / z: 659[MH] - , 661[M+H] + .

[0098] Embodiment 24

[0099] Synthesis of compound 11

[0100] Compound 5 (90 mg, 0.118 mmol) was dissolved in 10 mL of methanol / tetrahydrofuran (v / v=1:1) mixed solvent, 10% Pd / C (180 mg) was added, and the mixture was reacted for 24 h in a hydrogen atmosphere at room temperature and pressure. Pd / C was removed by filtration, and the solvent was concentrated and recovered to obtain 78 mg of a yellow oil with a yield of 98%. 1 H-NMR (DMSO-d 6 , 600MHz) δ: 12.51 (s, 5-OH), 7.91 (d, J=1.8Hz, 1H, H-2′), 7.68 (dd, J=8.4, 1.8Hz, 1H, H-6′), 7.12 (d, J=9.0Hz, 1H, H-5′), 6.78 (d, J=8.4Hz, 1H, H-8 ), 6.37 (d, J=15Hz, 1H, H-6), 5.74 (t, J=13.8Hz, 1H, H-1″), 5.31 (m, 1H, H- 5″), 5.22-5.25(m, 2H, H-3″, H-2″), 4.24(m, 1H, H-4″), 3.92(s, 3H, 4′-OCH 3 ), 3.86(s,6H,7,3′-OCH 3 ), 3.36-3.41(m, 1H, H-6″), 3.26-3.31(m, 1H, H-6″), 2.09, 2.06, 1.93, 1.77(s, each3H, CH 3 CO); 13 C-NMR (DMSO-d 6, 150MHz) δ: 177.0 (C-4), 169.8, 169.6, 169.5, 169.5 (4C, Ac-CO), 165.4 (C-7), 160.8 ( C-2), 156.8(C-5), 156.3(C-9), 151.4(C-4′), 147.9(C-3′), 133.2(C-3), 122.0(C-1′) , 121.9(C-6′), 112.6(C-2′), 111.1(C-5′), 105.0(C-10), 99.0(C-1″), 98.1(C-6), 92. 6(C-8), 70.3(C-2″), 69.9(C-3″), 68.9(C-4″), 67.1(C-5″), 60.7(C-6″), 56.2(4′-OCH 3 ), 55.7(3′-OCH 3 ), 55.5(7-OCH 3 ), 20.6, 20.3, 20.3, 20.2 (4C, Ac-CH 3 ); ESI-MS m / z: 673 [MH] - , 675[M+H] + .

[0101] Embodiment 25

[0102] Synthesis of compound 12

[0103] Compound 6 (90 mg, 0.118 mmol) was dissolved in 10 mL of methanol / tetrahydrofuran (v / v=1:1) mixed solvent, 10% Pd / C (180 mg) was added, and the mixture was reacted for 24 h in a hydrogen atmosphere at room temperature and pressure. Pd / C was removed by filtration, and the solvent was concentrated and recovered to obtain 78 mg of a yellow oil with a yield of 98%. 1 H-NMR (DMSO-d 6 , 600MHz) δ: 12.51 (s, 1H, 5-OH), 9.24 (s, 1H, 3′-OH), 7.60 (dd, J=9.0, 2.4Hz, 1H, H- 6'), 7.49 (d, J=1.8Hz, 1H, H-2'), 7.01 (d, J=9.0Hz, H-5'), 6.40 (d, J=1.8Hz, 1H, H- 8), 6.19 (d, J=1.8Hz, 1H, H-6), 5.62 (d, J=7.8Hz, 1H, H-1″), 5.23-5.25 (m, 1H, H-5″ ), 5.16-5.17(m, 2H, H-2″, H-3″), 4.15(t, J=18.6Hz, 1H, H-4″), 3.85(s, 3H, 4′-OCH 3), 3.80-3.82(m, 2H, H-6″), 2.12(s, 3H, CH 3 CO), 2.03 (s, 3H, CH 3 CO), 1.91(s, 3H, CH 3 CO), 1.78 (s, 3H, CH 3 CO); 13 C-NMR (DMSO-d 6 , 150MHz) δ: 177.0 (C-4), 169.8, 169.6, 169.5, 169.5 (4C, Ac-CO), 165.37 (C-7), 160.8 ( C-2), 156.8(C-5), 156.3(C-9), 151.4(C-4′), 147.9(C-3′), 133.2(C-3), 122.0(C-1′) , 121.9(C-6′), 112.6(C-2′), 111.1(C-5′), 105.0(C-10), 99.0(C-1″), 98.1(C-6), 92. 6(C-8), 70.3(C-2″), 69.9(C-3″), 68.9(C-4″), 67.1(C-5″), 60.7(C-6″), 55.8(4′-OCH 3 ), 20.6, 20.3, 20.3, 20.2 (4C, Ac-CH 3 ); ESI-MS m / z: 645[MH] - , 647[M+H] + .

[0104] Embodiment 26

[0105] Synthesis of compound 13

[0106] Compound 8 (60 mg, 0.118 mmol) was dissolved in 20 mL of anhydrous methanol, and 5 mg of sodium methoxide was added. The reaction was carried out at 50 °C. The reaction was monitored by TLC. The reaction stopped when the raw material point disappeared. The reaction was cooled to room temperature and the solvent was recovered under reduced pressure to obtain a yellow crude product. Silica gel column chromatography (dichloromethane / methanol = 100: 0 to 5: 1) gave 31 mg of a yellow solid with a yield of 66.1%. 1 H-NMR (DMSO-d 6, 600MHz) δ: 12.53 (s, 1H, 5-OH), 7.90 (s, 1H, H-2′), 7.63 (d, J=8.4Hz, 1H, H-2′), 7.09 (d, J=8.4Hz, H-5′), 6.73 (s, 1H, H-8), 6.36 (s, 1H, H-6), 5.56 (d, J=7.2Hz, 1H, H-1″), 5.35 (s, 1H, 4″-OH), 5.05 (s, 1H, 2″-OH), 4.97 (s, 1H, 3″-OH), 4.39 (s, 1H, 6″-OH), 3.83 (s, 3H, 4′-OCH 3 ), 3.82(s, 3H, 3′-OCH 3 ), 3.80(s, 3H, 7-OCH 3 ), 3.56 (d, J=14.4Hz, 1H, H-6″), 3.08-3.22 (m, 5H, H-2″, H-3″, H-4″, H-5″, H-6″); 13 C-NMR (DMSO-d 6 , 150MHz) δ: 177.6(C-4), 165.2(C-7), 162.0(C-2), 156.4(C-5), 156.4(C-9) , 151.1(C-4′), 148.0(C-3′), 133.6(C-3), 122.4(C-1′), 122.0(C-6′), 112. 7(C-2′), 111.2(C-5′), 105.1(C-10), 100.7(C-1″), 98.0(C-6), 92.4(C-8), 77.5(C-2″), 76.4(C-3″), 74.3(C-4″), 69.8(C-5″), 60.6(C-6″), 56.2(7-OCH 3 ), 55.7(3′-OCH 3 ), 55.6(4′-OCH 3 ); ESI-MS m / z: 505[MH] - , 507[M+H] + .

[0107] Embodiment 27

[0108] Synthesis of compound 14

[0109] Compound 9 (50 mg, 0.077 mmol) was dissolved in 20 mL of anhydrous methanol, 5 mg of sodium methoxide was added, and the reaction was carried out at 50 ° C. The reaction was monitored by TLC. The reaction stopped when the raw material point disappeared. The reaction was cooled to room temperature and the solvent was recovered under reduced pressure to obtain a yellow crude product. Silica gel column chromatography (dichloromethane / V methanol = 100: 0 to 5: 1) gave 32 mg of a yellow solid with a yield of 86.5%. 1 H-NMR (DMSO-d 6 , 600MHz) δ: 12.56 (s, 1H, 5-OH), 7.67 (dd, J=8.4, 2.4Hz, 1H, H-6′), 7.53 (d, J=2.4Hz, 1H, H-2′), 7.02 (d, J=8.4Hz, H-5′), 6.38 (s, 1H, H-8), 6.1 7 (s, 1H, H-6), 5.46 (d, J=9.0Hz, 1H, H-1″), 5.27 (s, 1H, 4″-OH), 5.05 (s, 1H, 2″-OH), 4.94 (s, 1H, 3″-OH), 4.26 (s, 1H, 6″-OH), 3.82 (s, 3H, 4′-OCH 3 ), 3.55(m, 1H, H-6″), 3.06-3.19(m, 5H, H-2″, H-3″, H-4″, H-5″, H-6″); 13 C-NMR (DMSO-d 6 , 150MHz) δ: 177.49(C-4), 164.46(C-7), 161.3(C-2), 156.4(C-5), 155.8(C-9 ), 150.3(C-4′), 145.9(C-3′), 133.60(C-3), 122.7(C-1′), 121.4(C-6′), 115 .7(C-2′), 111.4(C-5′), 104.0(C-10), 100.8(C-1″), 98.8(C-6), 93.6(C-8), 77.6(C-2″), 76.5(C-3″), 74.1(C-4″), 80.0(C-5″), 61.3(C-6″), 55.7(4′-OCH 3 ); ESI-MS m / z: 477[MH] - , 479[M+H] + .

[0110] Embodiment 28

[0111] Synthesis of compound 15

[0112] Compound 11 (50 mg, 0.077 mmol) was dissolved in 20 mL of anhydrous methanol, and 5 mg of sodium methoxide was added. The reaction was carried out at 50°C. The reaction was monitored by TLC. The reaction stopped when the raw material point disappeared. The reaction was cooled to room temperature and the solvent was recovered under reduced pressure to obtain a yellow crude product. Silica gel column chromatography (dichloromethane / methanol = 100: 0 to 5: 1) gave 32 mg of a yellow solid with a yield of 86.5%. 1 H-NMR (DMSO-d 6 , 600MHz) δ: 7.80 (d, J=2.4Hz, 1H, H-6′), 7.64 (d, J=9.0Hz, 1H, H-2′), 7.08 (d, J=8.4Hz, H-5′), 6.71 (s, 1H, H-8), 6.35 (s, 1H, H-6) , 5.50 (d, J=7.2Hz, 1H, H-1″), 5.18 (s, 1H, 4″-OH), 4.88 (s, 1H, 2″-OH), 4.53 (s, 1H, 3″-OH), 4.48 (s, 1H, 6″-OH), 3.84 (s, 3H, 4′-OCH 3 ), 3.82(s, 3H, 3′-OCH 3 ), 3.81(s, 3H, 3-OCH 3 ), 3.65 (m, 1H, H-5″), 3.54 (t, J=16.2Hz, 1H, H-3″), 3.37-3.47 (m, 4H, H-2″, H-4″, H-6″); 13 C-NMR (DMSO-d 6 , 150MHz) δ: 177.5(C-4), 165.2(C-7), 161.5(C-2), 156.5(C-5), 156.0(C-9) , 151.0(C-4′), 148.0(C-3′), 133.8(C-3), 122.4(C-1′), 121.7(C-6′), 112.8 (C-2′), 111.1(C-5′), 105.3(C-10), 101.6(C-1″), 98.1(C-6), 92.0(C-8), 7 6.0(C-2″), 73.1(C-4″), 71.3(C-4″), 68.0(C-5″), 60.3(C-6″), 56.1(4′-OCH 3 ), 56.0(3′-OCH 3 ), 55.6(7-OCH 3 ); ESI-MS m / z: 505[MH] - , 507[M+H] + .

[0113] Embodiment 29

[0114] Synthesis of compound 16

[0115] Compound 12 (50 mg, 0.077 mmol) was dissolved in 20 mL of anhydrous methanol, and 5 mg of sodium methoxide was added. The reaction was carried out at 50°C and monitored by TLC. The reaction stopped when the starting material point disappeared. The reaction was cooled to room temperature and the solvent was recovered under reduced pressure to obtain a yellow crude product. Silica gel column chromatography (dichloromethane / methanol = 100:0 to 5:1) gave 30 mg of a yellow solid with a yield of 81.1%. 1 H-NMR (DMSO-d 6 , 600MHz) δ: 12.53 (s, 1H, 5-OH), 7.74 (dd, J=2.4, 1.8Hz, 1H, H-6′), 7.49 (d, J=2.4Hz, 1H, H-2′), 6.97 (d, J=9.0Hz, H-5′), 6.35 (s, 1H, H-8), 6. 14 (s, 1H, H-6), 5.36 (d, J=7.2Hz, 1H, H-1″), 5.12 (br-s, 1H, 4″-OH), 4.83 (br-s, 1H, 2″-OH), 4.42 (br-s, 2H, 3″-OH, 6″-OH), 3.82 (s, 3H, 4′-OCH 3 ), 3.41-3.61 (m, 6H, H-2″, H-3″, H-4″, H-5″, H-6″); 13 C-NMR (DMSO-d 6 , 150MHz) δ: 177.4(C-4), 165.1(C-7), 161.2(C-2), 156.4(C-5), 155.7(C-9) , 150.0(C-4′), 146.0(C-3′), 133.8(C-3), 122.6(C-1′), 121.7(C-6′), 115.5 (C-2′), 111.3(C-5′), 103.7(C-10), 101.8(C-1″), 99.0(C-6), 93.7(C-8), 7 5.9(C-2″), 73.2(C-3″), 71.2(C-4″), 67.9(C-5″), 60.2(C-6″), 55.6(4′-OCH 3 ); ESI-MS m / z: 477[MH] - , 479[M+H] + .

[0116] Embodiment 30

[0117] Synthesis of compound 17

[0118] Compound 9 (130 mg, 0.2 mmol) was dissolved in 5 mL of dry DMF and anhydrous K 2 CO 3 (28 mg, 0.2 mmol) and benzyl bromide (26 μL, 0.2 mmol) were stirred at room temperature for 24 h, then 30 mL of ice water was added, the pH was adjusted to neutral with 3% dilute hydrochloric acid, and the mixture was extracted with ethyl acetate (30 mL×3). The organic layers were combined, washed with saturated brine (50 mL×2), dried over anhydrous MgSO4, filtered, and the filtrate was concentrated to give a yellow oily crude product. 91 mg of a yellow oily substance was obtained by silica gel column chromatography (cyclohexane / V ethyl acetate=2:1). The yield was 61.9%. 1 H-NMR (DMSO-d 6 , 600MHz) δ: 12.49 (s, 1H, 5-OH), 9.41 (s, 1H, 3′-OH), 7.61 (d, J=2.4Hz, 1H, H-2′), 7.59 (dd, J=6.6 , 1.8Hz, 1H, H-6′), 7.45 (d, J=7.8Hz, 2H, 7-O-Bn-Ar), 7.39 (t, J=15.6Hz, 2H, 7-O-Bn-Ar), 7.35(t , J=14.4Hz, 1H, 7-O-Bn-Ar), 7.04 (d, J=8.4Hz, 1H, H-5′), 6.83 (d, J=1.8Hz, 1H, H-8), 6.46 (d, J=1 .8Hz, 1H, H-6), 5.68 (d, J=7.8Hz, 1H, H-1″), 5.34 (t, J=19.2Hz, 1H, H-6″), 5.22 (s, 2H, 5-O-Bn-CH 2 ), 5.12 (t, J = 17.4Hz, 1H, H-6″), 4.98 (t, J = 19.2Hz, 1H, H-5″), 3.86-3.95 (m, 3H, H-3″, H-2″, H-4″), 3.84 (s, 3H, 4′-OCH 3 ), 2.01(s, 3H, CH 3 CO), 1.95(s, 3H, CH 3 CO), 1.94 (s, 3H, CH 3 CO), 1.80(s, 3H, CH 3 CO); 13 C-NMR (DMSO-d 6, 150MHz) δ: 177.0 (C-4), 169.8, 169.5, 169.34, 169.3 (4C, Ac-CO), 164.4 (C-7), 160.9 (C-2), 157.2 (C-5), 156.3(C-9), 150.5(C-4′), 145.9(C-3′), 136.1(7-O-Bn-Ar), 133.3(C-3), 127.9-128.6(5C, 7-O-Bn-Ar), 121.9(C-1′), 121.1(C-6′), 116.1(C-2′), 111.3(C-5′), 105.1(C-10), 98.7(C-1″), 98 .6(C-6), 93.3(C-8), 71.9(C-3″), 71.4(C-2″), 70.6(C-5″), 67.8(C-4″), 61.0(C-6″), 55.6(4′-OCH 3 ), 20.5, 20.4, 20.3, 20.1 (4C, Ac-CH 3 ); ESI-MS m / z: 735[MH] - , 737[M+] + .

[0119] Embodiment 31

[0120] Synthesis of compound 18

[0121] Compound 12 (150 mg, 0.23 mmol) was dissolved in 5 mL of dry DMF and anhydrous K 2 CO 3 (32 mg, 0.23 mmol) and benzyl bromide (30 μL, 0.2 mmol), stirred at room temperature for 24 h, added 30 mL of ice water, adjusted the pH value to neutral with 3% dilute hydrochloric acid, extracted with ethyl acetate (30 mL × 3), combined the organic layers, washed with saturated brine (50 mL × 2), anhydrous MgSO 4 The mixture was dried, filtered, and the filtrate was concentrated to obtain a yellow oily crude product. The crude product was purified by silica gel column chromatography (cyclohexane / ethyl acetate = 2:1) to obtain 94 mg of a yellow oily product with a yield of 55%. 1 H-NMR (DMSO-d 6,600MHz)δ:12.49(s,1H,5-OH),9.24(s,1H,3′-OH),7.62(dd,J=8.4,2.4Hz,1H,H-6′),7.53(d,J=2.4Hz,1H,H-2′),7.44(d,J=7.2Hz,2H,Bn-Ar-H-2,Bn-Ar-H-6),739(t,J=15.0Hz,2H,Bn-Ar-H-3,Bn-Ar-H-5),7.33(t,J=14.4Hz,1H,Bn-Ar-H-5),7.04(d,J=9.0Hz,1H,H-5′),6.81(d,J=1.8Hz,1H,H-8),6.45(d,J=2.4Hz,1H,H-6),5.62(d,J=7.8Hz,1H,H-1″),5.24-5.26(m,1H,H-6″),5.22(s,2H,7-O-Bn-CH 2 ),5.17-5.20(m,2H,H-5″,H-6″),4.17(m,1H,H-2″),3.85(s,3H,4′-OCH 3 ),3.82-3.84(m,2H,H-3″,H-4″),2.12(s,3H,CH 3 CO),2.03(s,3H,CH 3 CO),1.91(s,3H,CH 3 CO),1.76(s,3H,CH 3 CO); 13 C-NMR(DMSO-d 6 ,150MHz)δ:177.1(C-4),170.0,169.5,169.5,169.4(4C,Ac-CO),164.3(C-7),160.9(C-2),157.3(C-5),156.3(C-9),150.4(C-4′),146.0(C-3′),136.1(Bn-Ar-C-1),133.4(C-3),128.6(2C,7-O-Bn-Ar-C-3,5),128.2(7-O-Bn-Ar-C-4),127.9(7-O-Bn-Ar-C-2,6),122.2(C-1′),121.4(C-6′),116.0(C-2′),111.2(C-5′),105.1(C-10),98.9(C-1″),98.7(C-6),93.3(C-8),70.2(2C,7-O-Bn-CH 2, C-2″), 70.1(C-3″), 69.2(C-5″), 67.1(C-4″), 60.9(C-6″), 55.7(4′-OCH 3 ), 20.6, 20., 20.4, 20.2 (4C, Ac-CH 3 ); ESI-MS m / z: 735[MH] - , 737[M+H] + .

[0122] Embodiment 32

[0123] Pharmacological experiments:

[0124] The sample was accurately weighed using a 1 / 100,000 balance, and then dissolved with DMSO to a suitable concentration as a stock solution, stored at -20°C, and diluted with SUM149 cell culture medium to the required concentration before use.

[0125] SUM149 cells were cultured in the conventional method. When the cells proliferated to 70-80% cross-linking, the culture medium was removed, 2 mL of 0.25% trypsin solution was added, and the cells were placed in a 37°C, 5% CO 2 Digest in the incubator for 2-3 minutes until most cells are no longer attached to the wall under the microscope. Add 6 mL of culture medium to terminate the digestion and obtain a cell suspension. Centrifuge in a low-temperature centrifuge at 500 rpm for 3 minutes, remove the supernatant, add 6 mL of culture medium again, blow off the cells, and measure the cell density. Adjust the cell density to 3×10 3 / well, inoculated into 96-well plates, and placed in a 37°C, 5% CO 2 Incubate for 24 hours, then add the test sample. The experimental groups are: blank group and different dose groups. According to the preliminary test, each compound is tested at 4 concentrations, 3 replicates for each concentration, and 200 μL of culture medium per well. After addition, place at 37°C, 5% CO 2 After 48 h of incubation in the incubator, the culture medium was removed, and freshly prepared MTS reagent was added. The mixture was placed in a 37°C incubator for 2 h, and the OD value was measured at 490 nm on a microplate reader. The readings were transferred to Graphpad Prism software to calculate IC 50 Equal values.

[0126] The results showed (as shown in Table 2) that compounds 1b-1m, 1, and 3 showed strong growth inhibition effects on human triple-negative breast cancer cells. 50 The values ​​ranged from 1.38 to 11.98 μM; the remaining compounds had no obvious cytotoxic activity, and the inhibition rate at the maximum tested concentration (20 μM) was <50%.

[0127] Table 2 Effects of Compounds 1b-1m, 1, and 3 on human triple-negative breast cancer cell lines

[0128] Growth inhibition of SUM 149 (n=3)

[0129]

Claims

1. A flavonoid compound, characterized in that The structural formula is as follows:

2. Use of the flavonoid compound as claimed in claim 1 in the preparation of an anti-triple-negative breast cancer drug.